Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons prof. dr. P.G.M. (Peter) Mol

Publicaties

Arrival of biosimilars in respiratory medicine: towards improved access to biologics for patients

Biomarkers for neurodegenerative diseases in regulatory decision-making by the European Medicines Agency

Dispensing Patterns of Inhaled Asthma Medication Before and During COVID-19 Among Young Adults in the Netherlands: A Retrospective Inception Cohort Study

Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: A systematic review and meta-analysis of European studies published up to 22 January 2024

Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients

Mixed Impact of Direct Healthcare Professional Communications When Considering Proximal Outcomes and the Targeted Population: A Systematic Review

Navigating the Real World: A Scoping Review of Structured Frameworks to Effectively Identify, Evaluate, and Select Real-World Data Sources for Fit-for-Purpose Studies

Optimizing Patient Registries for Regulatory Decision Making - Key Learnings From an HMA/EMA Multistakeholder Workshop

Perspectives of People with Type 2 Diabetes Mellitus Towards a Decision Aid Assessing Preferences of Glucose-Lowering Drugs: The Dilemma of Choosing

Reassessing pembrolizumab dosing in NSCLC for methodological and clinical accuracy – Author's reply

Pers/media

CBG Collegedag 2024: uitdagingen veranderen in kansen

Towards a more efficient use of registry-based real-world data in Europe: the More-EUROPA project

Peter Mol en Patrick Vrijlandt namens Nederland in het Europese CHMP

Oratie Peter Mol over kennisuitwisseling tussen wetenschap en medicijnautoriteit